In Part 1 of this three-part series, we interview Alice Zhang, CEO of Verge Genomics, on the use of artificial intelligence to develop treatments for amyotrophic lateral sclerosis and other neurological disorders . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge